Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms-Reference-Cited by-同舟云学术

Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms

Published:2018-10-03 Issue:1 Volume:108 Page:26-36
ISSN:0028-3835
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Jensen Robert T.,Bodei Lisa,Capdevila Jaume,Couvelard Anne,Falconi Massimo^ORCID,Glasberg Simona^ORCID,Kloppel Günter,Lamberts Steven,Peeters Marc,Rindi Guido^ORCID,Rinke Anja,Rothmund Mathias,Sundin Anders,Welin Staffan,Fazio Nicola^ORCID,

Abstract

Recently, the European Neuroendocrine Tumor Society (ENETS) held working sessions composed of members of the advisory board and other neuroendocrine neoplasm (NEN) experts to attempt to identify unmet needs in NENs in different locations or with advanced/poorly differentiated NENs. This report briefly summarizes the main proposed areas of unmet needs in patients with functional and nonfunctional pancreatic NENs.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference69 articles.

1. Yadav S, Sharma P, Zakalik D. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study. Am J Clin Oncol. 2018 May;41(5):485–91.

2. Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al.; Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103(2):153–71.

3. Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):737–53.

4. Pavel M, O’Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al.; Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology. 2016;103(2):172–85.

5. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008 Jun;26(18):3063–72.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets;Journal of Controlled Release;2024-09

2. Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study;British Journal of Surgery;2024-08-30

3. Diagnostic Anatomic Imaging for Neuroendocrine Neoplasms: Maximizing Strengths and Mitigating Weaknesses;Journal of Computer Assisted Tomography;2024-04-24

4. Portal vein resection in pancreatic neuroendocrine neoplasms;Surgery;2024-04

5. SQSTM1/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumours;Endocrine;2024-02-22